Nexgel (NXGL) Equity Ratio (2018 - 2025)
Nexgel posted quarterly Equity Ratio of 0.47 for Q4 2025, down 10.77% year-on-year from 0.52 in Q4 2024, and down 2.57% on a QoQ basis from 0.48 in Q3 2025.
Nexgel (NXGL) has 8 years of Equity Ratio data on file, last reported at 0.47 in Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 10.77% year-over-year to 0.47; the trailing twelve-month figure through Dec 2025 stood at 0.47 (down 10.77% YoY), and the FY2025 full-year result was 0.47, down 10.77% from the prior year.
- Equity Ratio for Q4 2025 stood at 0.47, down from 0.48 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.74 in Q4 2022 and bottomed at 0.07 in Q2 2021.
- The 5-year median for Equity Ratio is 0.52 (2025), against an average of 0.52.
- Peak annual rise in Equity Ratio reached 2162.07% in 2021, while the deepest fall reached 66.35% in 2021.
- A 5-year view of Equity Ratio shows it stood at 0.71 in 2021, then gained by 3.62% to 0.74 in 2022, then slipped by 29.62% to 0.52 in 2023, then grew by 0.97% to 0.52 in 2024, then decreased by 10.77% to 0.47 in 2025.
- The last three Equity Ratio figures came in at 0.47 (Q4 2025), 0.48 (Q3 2025), and 0.52 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 0.88 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.47 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 0.74 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 0.73 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.35 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.67 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 0.66 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 0.30 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 0.52 |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.52 |
| Sep 30, 2024 | 0.47 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.52 |
| Sep 30, 2023 | 0.63 |
| Jun 30, 2023 | 0.64 |
| Mar 31, 2023 | 0.67 |
| Dec 31, 2022 | 0.74 |
| Sep 30, 2022 | 0.73 |
| Jun 30, 2022 | 0.68 |
| Mar 31, 2022 | 0.73 |
| Dec 31, 2021 | 0.71 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.07 |
| Mar 31, 2021 | 0.29 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.17 |
| Jun 30, 2020 | 0.20 |
| Mar 31, 2020 | 0.28 |
| Dec 31, 2019 | 0.20 |
| Sep 30, 2019 | 0.12 |
| Dec 31, 2018 | 0.38 |